IMMU-12. IMMUNOTHERAPY OF WILMS TUMOR 1 PEPTIDE VACCINATION IMPROVE PROGNOSIS OF RECURRENT GLIOBLASTOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA IN CHILDREN

BACKGROUND: We have ever proven safety and effectiveness of Wilms tumor 1 peptide (WT1) vaccination for newly-diagnosed or recurrent glioblastomas (GBM) in adult. But pediatric GBM and diffuse intrinsic pontine glioma (DIPG) are known to differ from adult GBM biologically. A pilot study designed to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Kagawa, Naoki, Hashii, Yoshiko, Hirayama, Ryuichi, Chiba, Yasuyoshi, Arita, Hideyuki, Yokota, Chisato, Achiha, Takamune, Kijima, Noriyuki, Fujimoto, Yasunori, Hashimoto, Naoya, Sugiyama, Haruo, Yoshimine, Toshiki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5475090/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox083.122
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak